The EORTC trials for limited stage Hodgkin's disease
- 1 January 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (11) , 1847-1850
- https://doi.org/10.1016/0959-8049(92)90018-w
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987Blood, 1989
- Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: Emphasis on the role of exploratory laparotomy and fractionationRadiotherapy and Oncology, 1988
- Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.Journal of Clinical Oncology, 1988
- Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.Journal of Clinical Oncology, 1987
- Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's DiseaseAnnals of Internal Medicine, 1986
- A multivariate analysis of prognostic factors in early stage hodgkin's diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Prognostic significance of the number of involved areas in the early stages of Hodgkin's diseaseCancer, 1984
- Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease.Journal of Clinical Oncology, 1984
- The EORTC treatment of early stages of hodgkin's disease: The role of radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Five-year results of the E.O.R.T.C. randomized study of splenectomy and spleen irradiation in clinical stages I and II of Hodgkin's diseasePublished by Elsevier ,1981